In cohort B ( transplant recipients ) , SVR12 was achieved by 96 % -98 % of patients without cirrhosis or with compensated cirrhosis , by 85 % -88 % of patients with moderate hepatic impairment , by 60 % -75 % of patients with severe hepatic impairment , and by all 6 patients with fibrosing cholestatic hepatitis .